# Cadonilimab for PD-1/PD-L1 Blockade-refractory, MSI-H/dMMR, Advanced Colorectal Cancer

> clinical trial · VERIFIED · 2026-06-24

Status: ACTIVE_NOT_RECRUITING · Sponsor: Sun Yat-sen University · Condition: Colorectal Cancer Stage IV

- Company: Sun Yat-sen University
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05426005

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.